Our results showed a reduction in the expression of HIF1α with atovaquone treatment under both normoxic, as well as hypoxic conditions, suggesting a significant role of atovaquone in suppressing hypoxia in breast-cancer cells (Figure 5D). This evidence concerns the gene HIF1A and breast cancer.